mortality/aging
N |
• viable
|
• protected from lethality because of pulmonary metastases following tail vein injection of LLC cells
|
neoplasm
• tumors derived from injected LLC cells appear paler and are poorly vascularlized
|
• of tumors derived from injected LLC cells
|
• impaired tumor growth following injection of Lewis Lung Carcinoma (LLC) cells
|
cardiovascular system
• tumors derived from injected LLC cells appear paler and are poorly vascularlized
|
homeostasis/metabolism
• significantly delayed following full thickness skin punch biopsy
|